The HER receptor family is involved in the regulation of normal breast growth and development (Zahnow, 2006), and overexpression of ERBB2/HER2 is associated with breast cancer (Krishnamurti and Silverman, 2014). The gene discussed is ERBB2; the disease is breast carcinoma.